Exact Sciences expects to double number of Cologuard tests completed in 2016

More than 100,000 Cologuard tests were completed by the end of 2015, but Exact Sciences expects the number of its stool DNA-based colorectal cancer screening tests completed in 2016 will more than double, according to a Post Bulletin report.

Advertisement

In addition to the growth in tests performed, Exact Sciences, based in Madison, Wis., is planning to build a new location in Madison. The $200 million project, which includes $46.7 million in public investment, is expected to add 400 jobs to the city, according to the report. Exact Sciences currently has more than 700 employees, with 275 hired in 2015.

More articles on gastroenterology:
FDA clears 5 GI/endoscopy devices in December
GPO Premier awards EndoChoice 3-year contract
Gastroenterologist Dr. Daniel Paulo dies at 82

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.